vs

Side-by-side financial comparison of PureCycle Technologies, Inc. (PCT) and Scilex Holding Co (SCLX). Click either name above to swap in a different company.

Scilex Holding Co is the larger business by last-quarter revenue ($4.8M vs $2.7M, roughly 1.8× PureCycle Technologies, Inc.). PureCycle Technologies, Inc. runs the higher net margin — -697.1% vs -961.9%, a 264.8% gap on every dollar of revenue.

PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.

Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.

PCT vs SCLX — Head-to-Head

Bigger by revenue
SCLX
SCLX
1.8× larger
SCLX
$4.8M
$2.7M
PCT
Higher net margin
PCT
PCT
264.8% more per $
PCT
-697.1%
-961.9%
SCLX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PCT
PCT
SCLX
SCLX
Revenue
$2.7M
$4.8M
Net Profit
$-18.8M
$-46.1M
Gross Margin
45.5%
Operating Margin
-2196.1%
-2317.8%
Net Margin
-697.1%
-961.9%
Revenue YoY
-67.8%
Net Profit YoY
71.0%
-613.7%
EPS (diluted)
$-0.14
$-4.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PCT
PCT
SCLX
SCLX
Q4 25
$2.7M
$4.8M
Q3 25
$2.4M
$10.6M
Q2 25
$1.6M
$9.9M
Q1 25
$1.6M
$5.0M
Q4 24
$0
$14.9M
Q3 24
$0
$14.4M
Q2 24
$0
$16.4M
Q1 24
$0
$10.9M
Net Profit
PCT
PCT
SCLX
SCLX
Q4 25
$-18.8M
$-46.1M
Q3 25
$-28.4M
$-257.8M
Q2 25
$-144.2M
$-44.0M
Q1 25
$8.8M
$-26.1M
Q4 24
$-64.7M
$-6.5M
Q3 24
$-90.6M
$-4.4M
Q2 24
$-48.2M
$-37.6M
Q1 24
$-85.6M
$-24.4M
Gross Margin
PCT
PCT
SCLX
SCLX
Q4 25
45.5%
Q3 25
68.5%
Q2 25
66.9%
Q1 25
72.3%
Q4 24
68.5%
Q3 24
73.9%
Q2 24
73.2%
Q1 24
64.7%
Operating Margin
PCT
PCT
SCLX
SCLX
Q4 25
-2196.1%
-2317.8%
Q3 25
-1602.2%
-1766.2%
Q2 25
-2763.5%
-207.2%
Q1 25
-2387.4%
-557.5%
Q4 24
-190.5%
Q3 24
-138.0%
Q2 24
-95.4%
Q1 24
-179.0%
Net Margin
PCT
PCT
SCLX
SCLX
Q4 25
-697.1%
-961.9%
Q3 25
-1167.5%
-2441.5%
Q2 25
-8741.8%
-445.1%
Q1 25
559.0%
-521.2%
Q4 24
-43.4%
Q3 24
-30.4%
Q2 24
-229.6%
Q1 24
-224.0%
EPS (diluted)
PCT
PCT
SCLX
SCLX
Q4 25
$-0.14
$-4.63
Q3 25
$-0.31
$-22.17
Q2 25
$-0.81
$-7.42
Q1 25
$0.05
$-2.26
Q4 24
$-0.40
$8.53
Q3 24
$-0.54
$-0.58
Q2 24
$-0.29
$-7.67
Q1 24
$-0.52
$-8.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PCT
PCT
SCLX
SCLX
Cash + ST InvestmentsLiquidity on hand
$156.7M
$5.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$45.9M
$-207.8M
Total Assets
$922.7M
$365.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PCT
PCT
SCLX
SCLX
Q4 25
$156.7M
$5.0M
Q3 25
$234.4M
$878.0K
Q2 25
$284.1M
$4.1M
Q1 25
$22.5M
$5.8M
Q4 24
$15.7M
$3.3M
Q3 24
$83.7M
$77.0K
Q2 24
$10.9M
$6.9M
Q1 24
$25.0M
$1.8M
Stockholders' Equity
PCT
PCT
SCLX
SCLX
Q4 25
$45.9M
$-207.8M
Q3 25
$68.2M
$-176.9M
Q2 25
$98.9M
$-249.0M
Q1 25
$238.2M
$-211.5M
Q4 24
$180.4M
$-192.6M
Q3 24
$241.4M
$-211.3M
Q2 24
$291.6M
$-214.7M
Q1 24
$336.8M
$-189.8M
Total Assets
PCT
PCT
SCLX
SCLX
Q4 25
$922.7M
$365.0M
Q3 25
$989.1M
$275.9M
Q2 25
$1.0B
$83.8M
Q1 25
$787.3M
$79.0M
Q4 24
$798.4M
$93.0M
Q3 24
$788.8M
$100.4M
Q2 24
$719.8M
$104.5M
Q1 24
$734.0M
$91.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PCT
PCT
SCLX
SCLX
Operating Cash FlowLast quarter
$-28.7M
$-17.5M
Free Cash FlowOCF − Capex
$-42.0M
FCF MarginFCF / Revenue
-1559.6%
Capex IntensityCapex / Revenue
495.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-183.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PCT
PCT
SCLX
SCLX
Q4 25
$-28.7M
$-17.5M
Q3 25
$-38.5M
$8.2M
Q2 25
$-36.7M
$7.0M
Q1 25
$-38.9M
$6.0M
Q4 24
$-31.8M
$2.5M
Q3 24
$-33.4M
$5.1M
Q2 24
$-40.4M
$2.3M
Q1 24
$-39.2M
$9.4M
Free Cash Flow
PCT
PCT
SCLX
SCLX
Q4 25
$-42.0M
Q3 25
$-42.4M
Q2 25
$-45.3M
Q1 25
$-53.9M
Q4 24
$-53.4M
Q3 24
$-42.6M
Q2 24
$-50.8M
Q1 24
$-53.5M
FCF Margin
PCT
PCT
SCLX
SCLX
Q4 25
-1559.6%
Q3 25
-1743.1%
Q2 25
-2747.1%
Q1 25
-3409.6%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
PCT
PCT
SCLX
SCLX
Q4 25
495.1%
Q3 25
160.3%
Q2 25
521.5%
Q1 25
949.6%
Q4 24
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
PCT
PCT
SCLX
SCLX
Q4 25
Q3 25
Q2 25
Q1 25
-4.40×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons